Do atypical antipsychotics fail to exert cognitive sparing effects?

NeuroReport

Volumn 14, Issue 3, 2003, Pages 505-509

  Papageorgiou, Charalabos ^a   Oulis, Panayiotis ^a   Vasios, Christos ^a   Matsopoulos, George K ^b   Uzunoglu, Nikolaos ^a   Rabavilas, Andreas ^a   Christodoulou, George N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL TECHNICAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

Atypical antipsychotics; Auditory hallucinations; Clozapine; Olanzapine; P600; Working memory

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; EVENT RELATED POTENTIAL; HUMAN; MALE; MEMORY; PRIORITY JOURNAL; SCHIZOPHRENIA; WORKING MEMORY;

EID: 0037416302     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200303030-00042     Document Type: Article

References (25)

1. David AS. Acta Psychiatr Scand 99, 95-104 (1999).
2. Hoffman RE. Acta Psychiatr Scand 99, 89-94 (1999).
3. Meltzer HY and McGurk SR. Schizophr Bull 25, 233-255 (1999).
4. Keefe SER, Siva GS, Perkins OD et al. Schizophr Bull 25, 201-222 (1999).
5. Fabiani M, Gratton G and Coles M. Event-related potentials; Methods, theory, and applications. In: Cacioppo J, Tassinary L and Bernston G (eds). Handbook of Psychophysiology. New York: Cambridge University Press; 2000, pp. 53-84.
6. Garcia-Larrea L and Cezanne-Bert G. Electroencephalogr Clin Neurol 108, 260-273 (1998).
7. Friederici AD, Yves von Cramon D and Kotz SA. Brain 122, 1033-1047 (1999).
8. Guillem F, Rougier A and Claverie B. J Cogn Neurosci 11, 437-458 (1999).
9. Guillem F, N'Kaoua B, Rougier A et al. Psychophysiology 32, 382-392 (1995).
10. Papageorgiou C, Kontaxakis V, Havaki-Kontaxaki BJ et al. Neuroreport 12, 2801-2806 (2001).
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental disorders. Washington DC: American Psychiatric Association; 1994.
12. Kay SR. Psychiatr Q 61, 163-178 (1990).
13. Oldfield RC. Neuropsychologia 9, 97-113 (1971).
14. Wechsler D. Manual for the Wechsler Adult Intelligence Scale. New York: Psychological Corporation; 1955.
15. Papageorgiou C, Liappas I, Asvestas P et al. Neuroreport 12, 1773-1778 (2001).
16. Jasper H. Electroencephalogr Clin Neurophysiol 10, 371-375 (1958).
17. Frodl T, Meisenzahl EM, Muller D et al. Schizophr Res 49, 107-119 (2001).
18. Shelley AM, Catts VS, Ward BP et al. Neuropsychopharmacology 16, 202-210 (1997).
19. Smolnik R, Perras B, Molle M et al. J Clin Psychopharmacol 20, 445-454 (2000).
20. Seeman P. Can J Psychiatry 47, 27-38 (2002).
21. Smith RC, Infante M, Singh A et al. Int J Neuropsychopharmacol 4, 239-250 (2001).
22. Perry W, Heaton RK, Potterat E et al. Schizophr Bull 27, 157-176 (2001).
23. Hoff AL, Sakuma M, Wieneke M et al. Am J Psychiatry 156, 1336-1341 (1999).
24. Cuesta MJ, Peralta V and Zarzuela A. Schizophr Res 48, 17-28 (2001).
25. Klein DN and Anderson RL. The behavioral high-risk paradigm in the mood disorders. In: Miller GA (ed.). The Behavioral High-risk Paradigm in Psychopathology. New York: Springer-Verlag; 1995, pp. 199-221.